title: Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment.
authors.forename: L
authors.initials: L
authors.lastname: Cantarini
authors.forename: O M
authors.initials: OM
authors.lastname: Lucherini
authors.forename: M
authors.initials: M
authors.lastname: Galeazzi
authors.forename: F
authors.initials: F
authors.lastname: Fanti
authors.forename: G
authors.initials: G
authors.lastname: Simonini
authors.forename: C T
authors.initials: CT
authors.lastname: Baldari
authors.forename: F
authors.initials: F
authors.lastname: Laghi Pasini
authors.forename: M
authors.initials: M
authors.lastname: De Martino
authors.forename: R
authors.initials: R
authors.lastname: Cimaz
mesh_terms: D002648:Child; D000068800:Etanercept; D005260:Female; D056660:Hereditary Autoinflammatory Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D009154:Mutation; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000235:genetics*; D013577:Syndrome
chemical_list: D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; C506235:TNFRSF1A protein, human; D000068800:Etanercept